Anzeige

Current Issue

2017: Issue 12 2017 (2213-2434)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

22 articles
1.

Noel C. Chan, M.B.B.S. (1,2), Jeffrey I. Weitz, M.D. (1,2,3)

1 Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada; 2 Department of Medicine, McMaster University, Hamilton, Canada; 3 Department of Biochemistry and Biomedical Sciences, McMaster
University, Hamilton, Canada

Thromb Haemost 2017 117 12: 2213-2214

https://doi.org/10.1160/TH17-10-0705

[Summary] [PDF] [Pay per view] [Export citation]
2.

Online Supplementary Material

Gregory Y. H. Lip (1,2), Jean Philippe Collet (3), Raffaele de Caterina (4), Laurent Fauchier (5), Deirdre A. Lane (1,2), Torben B. Larsen (6), Francisco Marin (7), Joao Morais(8), Calambur Narasimhan (9),  Brian Olshansky (10), Luc Pierard (11), Tatjana Potpara (12), Nizal Sarrafzadegan (13,14),  Karen Sliwa (15,16),  Gonzalo Varela (17), Gemma Vilahur (18), Thomas Weiss (19,20), Giuseppe Boriani (21), Bianca Rocca (2)2

1 Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; 2 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 3 ACTION Study Group, Institut De Cardiologie, Hôpital Pitié-Salpêtrière (APHP), Sorbonne Universite, Paris, France; 4 Institute of Cardiology, ‘G. d’Annunzio’ University, Chieti, Italy; 5 Centre Hospitalier Universitaire Trousseau et Faculté de Medicinde, Université François Rabelais, Tours, France; 6 Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark; 7 Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; 8 Department of Cardiology, Leiria Hospital Centre, Leiria, Portugal; 9 Department of Cardiac Electrophysiology, CARE Hospital, Hyderabad, Andhra Pradesh, India; 10 Clinical Cardiac Electrophysiology, Cardiology, Mercy Medical Center, Mason City, Iowa, United States; 11 Department of Cardiology, University Hospital Sart-Tilman, Liege, Belgium; 12 Cardiology Clinic, Clinical Center of Serbia, University of Belgrade School of Medicine, Belgrade, Serbia; 13 Isfahan Cardiovascular Research Center (WHO Collaborating Center), Cardiovascular Research Institute, Isfahan University of
Medical Sciences, Isfahan, Iran; 14 School of Population and Public Health, University of British
Columbia, Vancouver, Canada; 15 Hatter Institute for Cardiovascular Research in Africa, Faculty of
Health Sciences, University of Cape Town, South Africa; 16 Mary McKillop Institute, ACU, Melbourne, Australia
17 Servicio de Electrofisiología, Centro Cardiovascular Casa de Galicia, Hidalgos, Uruguay; 18 Cardiovascular Science Institute (ICCC), CIBERCV, IIB-Sant Pau, Hospital de la Sant Pau, Barcelona, Spain; 19 Medical Department, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria; 20 Faculty of Medicine, Sigmund Freud University, Vienna, Austria; 21 Department of Cardiology, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy; 22 Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy

Thromb Haemost 2017 117 12: 2215-2236

https://doi.org/10.1160/TH-17-10-0709

[Summary] [PDF] [Pay per view] [Export citation]
3.

C.L. Venema1 R.E.G. Schutgens (2), K. Fischer (1)

1 Van Creveldkliniek, University Medical Centre Utrecht, Utrecht, The Netherlands; 2 Department of Hematology, University Medical Centre Utrecht, Utrecht, The Netherlands

Thromb Haemost 2017 117 12: 2237-2242

https://doi.org/10.1160/TH17-01-0004

[Summary] [PDF] [Pay per view] [Export citation]
4.

Lai Heng Lee (1,2,3), Alexander Gallus (4,5),  Ravul Jindal (6), Chen Wang (7,8), Chau-Chung Wu (9,10)

1 Department of Haematology, Singapore General Hospital, Singapore; 2 Yong Loo Lin School of Medicine, National University of Singapore, Singapore; 3 Duke-NUS Medical School, Singapore; 4 Department of Haematology, Flinders University, Adelaide, SA, Australia; 5 Flinders Medical Centre, Adelaide, SA, Australia; 6 Vascular Surgery, Fortis Hospital, Mohali, India; 7 National Clinical Research Center of Respiratory Diseases,
Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China; 8 Department of Respiratory Medicine, Capital Medical University, Beijing, China; 9 Department of Internal Medicine (Cardiology Section), National Taiwan University Hospital, Taipei, Taiwan; 10 Graduate Institute of Medical Education and Bioethics, College of Medicine, National Taiwan University, Taipei, Taiwan

Thromb Haemost 2017 117 12: 2243-2260

https://doi.org/10.1160/TH17-02-0134

[Summary] [PDF] [Pay per view] [Export citation]
5.

Online Supplementary Material

María Asunción Esteve-Pastor, MD (1,2), José Miguel Rivera-Caravaca, RN, MSc (1,3), Alena Shantsila, MD, PhD (1), Vanessa Roldán, MD, PhD (3),  Gregory Y. H. Lip, MD (1,4), Francisco Marín, MD, PhD (2)

1 Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; 2 Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIBArrixaca), CIBER-CV, Murcia, Spain; 
3 Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain; 4 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Thromb Haemost 2017 117 12: 2261-2266

https://doi.org/10.1160/TH17-10-0710

[Summary] [PDF] [Pay per view] [Export citation]
6.

Online Supplementary Material

Katsiaryna Bykov (1), Rhonda L. Bohn (2), Bruce M. Ewenstein (3), John D. Seeger (4), Jerry Avorn (1), Brian T. Bateman (1)

1 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States; 2 Bohn Epidemiology, Boston, Massachusetts, United States; 3 Research and Development, Shire, Cambridge, Massachusetts,
United States; 4 Optum Epidemiology, Boston, Massachusetts, United States

Thromb Haemost 2017 117 12: 2267-2273

https://doi.org/10.1160/TH17-05-0365

[Summary] [PDF] [Pay per view] [Export citation]
7.

Maria Elisa Mancuso1 Kathelijn Fischer (2,3), Elena Santagostino (1), Johannes Oldenburg (4), Helen Platokouki (5), Cristoph Königs (6), Carmen Escuriola-Ettingshausen (7),  George E. Rivard (8), Ana Rosa Cid (9),  Manuel Carcao (10),  Rolf Ljung (11), Pia Petrini (12),  Carmen Altisent (13),  Gili Kenet (14), Raina Liesner (15),  Karin Kurnik (16),  Günther Auerswald (17),  Hérvè Chambost (18),  Anne Mäkipernaa (19), Angelo ClaudioMolinari (20),  Mike Williams (21),  H.Marijke van den Berg (3); on behalf of the European Pediatric
Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with
INhibitors) Study Group

1 Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy; 2 Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands; 3 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands; 4 Institut für Experimentelle Hämatologie und Transfusionsmedizin, Universitätsklinikum Bonn, Bonn, Germany; 5 St. Sophia Children’s Hospital, Haemophilia-Haemostasis Unit, Athens, Greece; 6 Department of Pediatrics, J.W. Goethe University Hospital, Frankfurt, Germany; 7 Hämophilie Zentrum Rhein Main GmbH, Mörfelden-Walldorf, Germany; 8 Division of Hematology/Oncology, Hôpital St Justine, Montréal, Canada; 9 Unidad de Hemostasia y Trombosis, Hospital Universitario y Politécnico La Fe, Valencia, Spain; 10 Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Canada; 11 Department of Pediatrics and Malmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden; 12 Department of Pediatrics, Clinic of Coagulation Disorders, Karolinska Hospital, Stockholm, Sweden; 13 Unitat d’Hemofilia, Vall d’Hebron University Hospital, Barcelona, Spain; 14 National Hemophilia Center, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel; 15 Hemophilia Center, Department of Haematology, Great Ormond
Street Hospital for Children, London, United Kingdom; 16 Dr. V. Haunersches Kinderspital, University of Munich, Germany; 17 Gesundheit Nord, Klinikum Bremen Mitte, Prof.-Hess-Kinderklinik, Bremen, Germany; 18 APHM, Service d’Hématologie Pédiatrique, Hôpital La Timone and Aix-Marseille University, Inserm U1062,arseille, France; 19 Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland; 20 Dipartimento di Ematologia ed Oncologia, Unità Trombosi ed Emostasi, Ospedale Pediatrico Giannina Gaslini, Genua, Italy; 21 Department of Haematology, The Children’s

Thromb Haemost 2017 117 12: 2274-2282

https://doi.org/10.1160/TH17-01-0059

[Summary] [PDF] [Pay per view] [Export citation]
8.

Online Supplementary Material

Francesca Rauzi (1), Erica Smyth (1), Michael Emerson (1)

Section of Molecular Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom

Thromb Haemost 2017 117 12: 2283-2290

https://doi.org/10.1160/TH17-04-0250

[Summary] [PDF] [Pay per view] [Export citation]
9.

Online Supplementary Material

Anders Nissen Bonde (1), Gregory Y. H. Lip (2), Anne-Lise Kamper (3), Laila Staerk (1), Christian Torp-Pedersen (4), Gunnar Gislason (1,5,6), Jonas Bjerring Olesen (1)

1 Department of Cardiology, Copenhagen University Hospital Gentofte, Gentofte, Denmark; 2 Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; 3 Department of Nephrology, Copenhagen University Hospital Rigshospitalet, Righshospitalet, Denmark; 4 Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark; 5 The Danish Heart Foundation, Copenhagen, Denmark; 6 The National Institute of Public Health,

Thromb Haemost 2017 117 12: 2291-2299

https://doi.org/10.1160/TH17-03-0198

[Summary] [PDF] [Pay per view] [Export citation]
10.

Online Supplementary Material

Lennart Beckmann (1), Christina Dicke (1), Brigitte Spath (1), Carina Lehr1 Bianca Sievers (1), Anna Klinke (2),
Stephan Baldus (2), Volker Rudolph (2), Florian Langer (1)

1 II. Medizinische Klinik und Poliklinik, Hubertus Wald Tumorzentrum – Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Hamburg, Germany; 2 Medizinische Klinik III, Herzzentrum, Uniklinik Köln, Köln, Germany

Thromb Haemost 2017 117 12: 2300-2311

https://doi.org/10.1160/TH17-04-0266

[Summary] [PDF] [Pay per view] [Export citation]
11.

Irene Lopez-Vilchez (1), Didac Jerez-Dolz (1), Maribel Diaz-Ricart (1), Victor Navarro (2), M. Urooj Zafar (3),
Javier Zamorano-Leon (4), Antonio Lopez-Farre (4), Juan J. Badimon (3), Cristobal Gasto (2), Gines Escolar (1)

1 Department of Hematopathology, Hospital Clinic of Barcelona, Biomedical Diagnosis Centre (CDB), Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; 2 Department of Psychiatry, Hospital Clinic of Barcelona, Clinic Institute of Neurosciences, Barcelona, Spain; 3 Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States; 4 Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain

Thromb Haemost 2017 117 12: 2312-2321

https://doi.org/10.1160/TH17-04-0288

[Summary] [PDF] [Pay per view] [Export citation]
12.

Online Supplementary Material

Viola Lorenz (1), Haley Ramsey (1), Zhi-Jian Liu (1), Joseph Italiano Jr. (2), Karin Hoffmeister (2,3), Sihem Bihorel (4,5), Donald Mager (4), Zhongbo Hu (6), William B. Slayton (6), Benjamin T. Kile (7,8),
Martha Sola-Visner (1), Francisca Ferrer-Marin (1,9)

Thromb Haemost 2017 117 12: 2322-2333

https://doi.org/10.1160/TH17-06-0433

[Summary] [PDF] [Pay per view] [Export citation]
13.

Matteo Becatti1 Rossella Marcucci2 Amanda Mannucci1 Anna Maria Gori2,3 Betti Giusti2
Francesco Sofi2 Lucia Mannini4 Anna Paola Cellai4 Agatina Alessandrello Liotta4
Marco Mugnaini5 Giacomo Emmi2 Domenico Prisco2 Niccolò Taddei1 Claudia Fiorillo1

1 Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Don Carlo Gnocchi Foundation, IRCCS, Florence, Italy; 4 Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 5 Department of Information Engineering and Mathematics,
University of Siena, Siena, Italy

Thromb Haemost 2017 117 12: 2334-2345

https://doi.org/10.1160/TH17-05-0356

[Summary] [PDF] [Pay per view] [Export citation]
14.

Online Supplementary Material

Bernd Hewing (1,2,3), Rena Ellerbroek (1), Sebastian Chi-Diep Au (1,3), Verena Stangl (1,3), Henryk Dreger (1,3), Michael Laule (1), Herko Grubitzsch (4), Fabian Knebel (1,2,3), Gert Baumann (1), Antje Ludwig (1,3), Karl Stangl (1,3)

1 Medizinische Klinik m.S. Kardiologie und Angiologie, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany; 2 Berlin Institute of Health (BIH), Berlin, Germany; 3 DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany; 4 Klinik für Kardiovaskuläre Chirurgie, Charité-Universitätsmedizin
Berlin, Campus Mitte, Berlin, Germany

Thromb Haemost 2017 117 12: 2346-2355

https://doi.org/10.1160/TH17-05-0341

[Summary] [PDF] [Pay per view] [Export citation]
15.

Online Supplementary Material

Artur M. Burylo (1,2), Vincent A. de Weger (1,2), Frederik E. Stuurman (1), Jos H. Beijnen (2,3,4), Jan H. M. Schellens (1,2,4)

1 Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 2 Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 3 Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 4 Department of Pharmaceutical Sciences, Utrecht University,
Utrecht, The Netherlands

Thromb Haemost 2017 117 12: 2356-2368

https://doi.org/10.1160/TH17-04-0254

[Summary] [PDF] [Pay per view] [Export citation]
16.

Online Supplementary Material

Sven Poli1 Florian Härtig (1), Charlotte Spencer (1), Matthias Ebner (3), Ingvild Birschmann (4),
Joachim Kuhn (4), Susanne Faix (2), Ulf Ziemann (1), Hans-Ulrich Häring (2,5,6), Rainer Lehmann (2,5,6),
Andreas Peter (2,5,6), Sebastian Hörber (2)

1 Department of Neurology and Stroke, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; 2 Division of Endocrinology, Diabetology, Va scular Medicine, Nephrology and Clinical Chemistry, Department of Internal Medicine, University of Tübingen, Germany; 3 Department of Internal Medicine and Cardiology, Charité University Medicine Berlin – Campus Virchow Klinikum, Berlin, Germany; 4 Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center, Bad Oeynhausen, Ruhr University, Bochum, Germany; 5 Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany; 6 German Center for Diabetes Research (DZD), München-Neuherberg, Germany

Thromb Haemost 2017 117 12: 2369-2375

https://doi.org/10.1160/TH17-04-0280

[Summary] [PDF] [Pay per view] [Export citation]
17.

Online Supplementary Material

Michał Mazurek (1,2), Menno V. Huisman (3), Kenneth J. Rothman (4), Miney Paquette (5), Christine Teutsch (6), Hans-Christoph Diener (7), Sergio J. Dubner (8), Jonathan L. Halperin (9), Chang Sheng Ma (10), Kristina Zint (11), Amelie Elsaesser (12), Shihai Lu (13), Gregory Y. H. Lip (1,14) on behalf of the GLORIA-AF Investigators

1 Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom
2 Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland; 3 Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands; 4 RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina, United States; 5 Department of Medicine, Boehringer Ingelheim, Burlington, Canada; 6 Department of Clinical Development and Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; 7 Department of Neurology, University of Duisburg-Essen, Duisburg, Germany; 8 Clínica y Maternidad Suizo Argentina, Buenos Aires, Argentina; 9 Icahn School of Medicine at Mount Sinai, New York, New York, United States; 10 Department of Cardiology, Atrial Fibrillation Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China; 11 Department of Cardiology, Atrial Fibrillation Center, Boehringer Ingelheim, Ingelheim, Germany; 12 Department of Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; 13 Department of Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States; 14 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Thromb Haemost 2017 117 12: 2376-2388

https://doi.org/10.1160/TH17-08-0555

[Summary] [PDF] [Pay per view] [Export citation]
18.

Gerald Chi (1), Samuel Z. Goldhaber (2), Russell D. Hull (3), Adrian F. Hernandez (4), Mathieu Kerneis (1), Fahad Al Khalfan(1), Alexander T. Cohen (5), Robert A. Harrington (6), C. Michael Gibson (1)

1 Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States; 2 Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States; 3 Division of Cardiology, Faculty of Medicine, University of Calgary, Alberta, Canada; 4 Duke University and Duke Clinical Research Institute, Durham, North Carolina, United States; 5 Department of Haematological Medicine, Guy’s and St Thomas’ Hospitals, King’s College, London, United Kingdom; 6 Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California, United States

Thromb Haemost 2017 117 12: 2389-2395

https://doi.org/10.1160/TH17-08-0538

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

Antonio González-Pérez (1,2), David Gaist (3,4), Francisco J. de Abajo (5,6,7), María E. Sáez (1,2), Luis A. García Rodríguez (2)

Thromb Haemost 2017 117 12: 2396-2405

https://doi.org/10.1160/TH17-05-0342

[Summary] [PDF] [Pay per view] [Export citation]
20.

Andria Medina1 Gary Raskob (2), Walter Ageno (3), Alexander T. Cohen (4), Marjolein P.A. Brekelmans (5), Cathy Z. Chen (6), Michael A. Grosso (7), Michele F. Mercuri (7), Annelise Segers (8), Peter Verhamme (9),
Thomas Vanassche(9), Philip S. Wells (1), 0 Min Lin (7), Shannon M. Winters (6), Jeffrey I. Weitz1 (1), Harry R. Büller (5)

1 Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States; 2 College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States; 3 Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy; 4 Department of Haematological Medicine, Guy’s and St Thomas’ Hospitals, King’sCollege London,Westminster, London, United Kingdom; 5 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; 6 Global Medical Affairs, Daiichi Sankyo Inc, Basking Ridge, New Jersey, United States; 7 Clinical Development, Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United States; 8 ITREAS Clinical Research, Amsterdam, The Netherlands; 9 Vascular Medicine and Hemostasis, University of Leuven, Leuven, Belgium; 10 Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; 11 Thrombosis & Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada

Thromb Haemost 2017 117 12: 2406-2414

https://doi.org/10.1160/TH17-05-0523

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-22